April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Pharmacokinetics of Intravitreal Glial Cell Line-Derived Neurotrophic Factor: Experimental Studies in Pigs
R. Ejstrup; J. Kiilgaard; B. Tucker; H. Klassen; M. J. Young; M. la Cour
Author Affiliations & Notes
  • R. Ejstrup
    Eye Department, Glostrup Hospital, Uni. of Copenhagen, Glostrup Hospital, Copenhagen, Denmark
  • J. Kiilgaard
    Eye Department, Rigshospitalet, Copenhagen, Denmark
  • B. Tucker
    The Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts
  • H. Klassen
    Department of ophthalmology, School of Medicine, University of California, Irvine, California
  • M. J. Young
    The Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts
  • M. la Cour
    Eye Department, Glostrup Hospital, Uni. of Copenhagen, Glostrup Hospital, Copenhagen, Denmark
  • Footnotes
    Commercial Relationships  R. Ejstrup, None; J. Kiilgaard, None; B. Tucker, None; H. Klassen, None; M.J. Young, None; M. la Cour, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 6234. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Pharmacokinetics of Intravitreal Glial Cell Line-Derived Neurotrophic Factor: Experimental Studies in Pigs
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      R. Ejstrup, J. Kiilgaard, B. Tucker, H. Klassen, M. J. Young, M. la Cour; Pharmacokinetics of Intravitreal Glial Cell Line-Derived Neurotrophic Factor: Experimental Studies in Pigs. Invest. Ophthalmol. Vis. Sci. 2009;50(13):6234.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To establish the intravitreal pharmacokinetics of glial cell line-derived neurotrophic factor (GDNF) in porcine eyes under near physiological conditions (general anesthesia.)

Methods: : In 12 pigs 24 eyes were injected intravitreally with 100 ng of GDNF. An injection solution of 500 µg/ml in pbs was prepared. After paracenthesis of 0.2 ml of aqueous humor from the anterior chamber 0.2 ml of injection solution was administered intravitreally with a 30G needle. Postoperative complications and intraocular pressure were assessed by indirect ophthalmoscopy and bimanual palpation after the procedure. Enucleation of eyes was performed at either 1h, 2h, 3h, 6h, 1day or 2 days postoperatively. Eyes were immediately dissected and all vitreous was collected and frozen. The vitreous samples were prepared by sonification and spinning before the GDNF content was determined by enzyme-linked immunosorbent assay (ELISA.)

Results: : At the early time points (1, 2 and 3h) limited distribution of GDNF was noted and great variability of the GDNF concentrations between samples existed. The lowest values were obtained from the 1h samples. At later time points GDNF was cleared from the vitreous with an estimated half life of 1.5 day. Assuming first-order decay a mathematical extrapolation was done that predicted levels of GDNF to be greater than the minimal detectable concentration of the ELISA for 9 days. None of the 12 eyes showed any complications.

Conclusions: : In the pig intravitreal injection of pure GDNF appears to be safe and intravitreally administered GDNF is equally distributed in the vitreous six hours post injection. GDNF has a half life of 1.5 day in the porcine vitreous which is about half that of ranibizumab even though it is less than one third of its molar mass. Comparisons with vitrectomized porcine eyes should be undertaken to help determine the role of the vitreous body in clearance of GDNF.

Keywords: growth factors/growth factor receptors • injection • neuroprotection 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept